Cargando…
Corrigendum to: Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells
Autores principales: | Park, Mijin, Moon, Byul, Kim, Jong-Hwan, Park, Seung-Jin, Kim, Seon-Kyu, Park, Kihyun, Kim, Jaehoon, Kim, Seon-Young, Kim, Jeong-Hoon, Kim, Jung-Ae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589369/ https://www.ncbi.nlm.nih.gov/pubmed/36254712 http://dx.doi.org/10.14348/molcells.2022.0009.e |
Ejemplares similares
-
Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells
por: Park, Mijin, et al.
Publicado: (2022) -
Corrigendum: ATBS1-INTERACTING FACTOR 2 negatively regulates dark- and brassinosteroid-induced leaf senescence through interactions with INDUCER OF CBF EXPRESSION 1
por: Kim, Yoon, et al.
Publicado: (2020) -
Corrigendum: Hemorheologic Alterations in Patients with Type 2 Diabetes Mellitus Presented with an Acute Myocardial Infarction
por: Park, Kyu-Hwan, et al.
Publicado: (2018) -
Corrigendum: Necessity for a National Carcinogen List in Korea, Based on International Harmonization
por: Leem, Jong Han, et al.
Publicado: (2013) -
Synergistic antitumor activity of sorafenib and MG149 in hepatocellular carcinoma cells
por: Moon, Byul, et al.
Publicado: (2022)